Evaluation of genome-wide expression profiles of blood and sputum neutrophils in cystic fibrosis patients before and after antibiotic therapy

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Conese, Massimo ^a   Castellani, Stefano ^a   Lepore, Silvia ^b   Palumbo, Orazio ^c   Manca, Antonio ^d   Santostasi, Teresa ^e   Polizzi, Angela Maria ^e   Copetti, Massimiliano ^c   Di Gioia, Sante ^a   Casavola, Valeria ^e   Guerra, Lorenzo ^e   Diana, Anna ^d   Montemurro, Pasqualina ^e   Mariggiò, Maria Addolorata ^e   Gallo, Crescenzio ^a   Maffione, Angela Bruna ^a   Carella, Massimo ^c  

^a UNIVERSITY OF FOGGIA   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d POLICLINICO   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA ARRESTIN 1; C REACTIVE PROTEIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; MEROPENEM; MINOCYCLINE; PHORBOL 13 ACETATE 12 MYRISTATE; TEICOPLANIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; APOPTOSIS; ARRB1 GENE; ARTICLE; BLOOD NEUTROPHIL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOM3Z GENE; DOWN REGULATION; EXOCYTOSIS; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HVCN1 GENE; LEUKOCYTE COUNT; LUNG FIBROSIS; LUNG FUNCTION TEST; MALE; MICROARRAY ANALYSIS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; NUCLEOTIDE SEQUENCE; PMAIP1 GENE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY BURST; SCHOOL CHILD; SPUTUM ANALYSIS; SPUTUM NEUTROPHIL; SRGAP2 GENE; UNINDEXED SEQUENCE; UPREGULATION; YOUNG ADULT; BLOOD; CASE CONTROL STUDY; CYSTIC FIBROSIS; CYTOLOGY; DEMOGRAPHY; DNA MICROARRAY; DRUG EFFECTS; GENETICS; HUMAN GENOME; INFLAMMATION; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; SPUTUM;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD; CYSTIC FIBROSIS; DEMOGRAPHY; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; INFLAMMATION; LUNG; MALE; NEUTROPHILS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SPUTUM; UP-REGULATION; YOUNG ADULT;

EID: 84905483128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104080     Document Type: Article

References (46)

1. Ratjen F, Doring G (2003) Cystic fibrosis. The Lancet 361: 681-689. (Pubitemid 36246556)
2. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, et al. (1995) Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152: 2111-2118.
3. Muhlebach MS, Reed W, Noah TL (2004) Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol 37: 393-399. (Pubitemid 38620060)
4. Rosenfeld M (2007) An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all. Proc Am Thorac Soc 4: 299-301.
5. Sagel SD (2003) Noninvasive biomarkers of airway inflammation in cystic fibrosis. Curr Opin Pulm Med 9: 516-521.
6. Dorlochter L, Carlsson M, Olafsdottir EJ, Roksund OD, Rosendahl K, et al. (2004) Anti-neutrophil cytoplasmatic antibodies and lung disease in cystic fibrosis. J Cyst Fibros 3: 179-183. (Pubitemid 39194073)
7. Downey DG, Brockbank S, Martin SL, Ennis M, Elborn JS (2007) The effect of treatment of cystic fibrosis pulmonary exacerbations on airways and systemic inflammation. Pediatr Pulmonol 42: 729-735. (Pubitemid 47242871)
8. Downey DG, Martin SL, Dempster M, Moore JE, Keogan MT, et al. (2007) The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis. Pediatr Pulmonol 42: 216-220. (Pubitemid 46417692)
9. Levy H, Kalish LA, Huntington I, Weller N, Gerard C, et al. (2007) Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 42: 256-262. (Pubitemid 46417699)
10. Horsley AR, Davies JC, Gray RD, Macleod KA, Donovan J, et al. (2013) Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 68: 532-539.
11. Shoki AH, Mayer-Hamblett N, Wilcox PG, Sin DD, Quon BS (2013) Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations. Chest 144: 1659-1670.
12. Jensen PO, Moser C, Kharazmi A, Presler T, Koch C, et al. (2006) Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia. J Cyst Fibros 5: 145-151. (Pubitemid 44081131)
13. Moser C, Jensen PO, Pressler T, Frederiksen B, Lanng S, et al. (2005) Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Apmis 113: 400-409. (Pubitemid 40965536)
14. Tirelli AS, Colombo C, Torresani E, Fortunato F, Biffi A, et al. (2013) Effects of treatment in the levels of circulating cytokines and growth factors in cystic fibrosis and dialyzed patients by multi-analytical determination with a biochip array platform. Cytokine 62: 413-420.
15. Colombo C, Costantini D, Rocchi A, Cariani L, Garlaschi ML, et al. (2005) Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Ped Pulmunol 40: 15-21. (Pubitemid 40917903)
16. Hauber HP, Gholami D, Koppermann G, Heuer HE, Meyer A, et al. (2003) Increased expression of Interleukin-13 but not Interleukin-4 in cystic fibrosis patients. J Cyst Fibros 2: 189-194. (Pubitemid 37376496)
17. Corvol H, Fitting C, Chadelat K, Jacquot J, Tabary O, et al. (2003) Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 284: L997-1003.
18. Hauber HP, Beyer IS, Meyer A, Pforte A (2004) Decreased interleukin-18 expression in BAL cells and peripheral blood mononuclear cells in adult cystic fibrosis patients. J Cyst Fibros 3: 129-131. (Pubitemid 38987024)
19. Brazova J, Sediva A, Pospisilova D, Vavrova V, Pohunek P, et al. (2005) Differential cytokine profile in children with cystic fibrosis. Clin Immunol 115: 210-215. (Pubitemid 40703901)
20. Zaman MM, Gelrud A, Junaidi O, Regan MM, Warny M, et al. (2004) Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol 11: 819-824. (Pubitemid 39280584)
21. Saavedra MT, Hughes GJ, Sanders LA, Carr M, Rodman DM, et al. (2008) Circulating RNA transcripts identify therapeutic response in cystic fibrosis lung disease. Am J Respir Crit Care Med 178: 929-938.
22. Nick JA, Sanders LA, Ickes B, Briones NJ, Caceres SM, et al. (2013) Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis. Thorax 68: 929-937.
23. Petit-Bertron AF, Tabary O, Corvol H, Jacquot J, Clement A, et al. (2008) Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10. Cytokine 41: 54-60.
24. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, et al. (2008) Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci U S A 105: 4335-4339. (Pubitemid 351754381)
25. Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, et al. (2009) Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci U S A 106: 5779-5783.
26. Adib-Conquy M, Pedron T, Petit-Bertron AF, Tabary O, Corvol H, et al. (2008) Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med 14: 36-44. (Pubitemid 351356884)
27. Wolter JM, Rodwell RL, Bowler SD, McCormack JG (1999) Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. Clin Diagn Lab Immunol 6: 260-265. (Pubitemid 29124975)
28. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113.
29. Yeung KY, Ruzzo WL (2001) Principal component analysis for clustering gene expression data. Bioinformatics 17: 763-774. (Pubitemid 32970476)
30. Bankey PE, Banerjee S, Zucchiatti A, De M, Sleem RW, et al. (2010) Cytokine induced expression of programmed death ligands in human neutrophils. Immunol Lett 129: 100-107.
31. Goss CH, Burns JL (2007) Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis. Thorax 62: 360-367. (Pubitemid 46580580)
32. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, et al. (2010) Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med 182: 627-632.
33. Mason FM, Heimsath EG, Higgs HN, Soderling SH (2011) Bi-modal regulation of a formin by srGAP2. J Biol Chem 286: 6577-6586.
34. Guo S, Bao S (2010) srGAP2 arginine methylation regulates cell migration and cell spreading through promoting dimerization. J Biol Chem 285: 35133-35141.
35. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058. (Pubitemid 30324238)
36. Kim JY, Ahn HJ, Ryu JH, Suk K, Park JH (2004) BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J Exp Med 199: 113-124.
37. Sun Y, Leaman DW (2005) Involvement of Noxa in cellular apoptotic responses to interferon, double-stranded RNA, and virus infection. J Biol Chem 280: 15561-15568. (Pubitemid 40616672)
38. Kirschnek S, Vier J, Gautam S, Frankenberg T, Rangelova S, et al. (2011) Molecular analysis of neutrophil spontaneous apoptosis reveals a strong role for the pro-apoptotic BH3-only protein Noxa. Cell Death Differ 18: 1805-1814.
39. McKeon DJ, Condliffe AM, Cowburn AS, Cadwallader KC, Farahi N, et al. (2008) Prolonged survival of neutrophils from patients with Delta F508 CFTR mutations. Thorax 63: 660-661. (Pubitemid 351969268)
40. Moriceau S, Lenoir G, Witko-Sarsat V (2010) In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance. J Innate Immun 2: 260-266.
41. Moriceau S, Kantari C, Mocek J, Davezac N, Gabillet J, et al. (2009) Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients. J Immunol 182: 7254-7263.
42. Morgan D, Capasso M, Musset B, Cherny VV, Rios E, et al. (2009) Voltagegated proton channels maintain pH in human neutrophils during phagocytosis. Proc Natl Acad Sci U S A 106: 18022-18027.
43. Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, et al. (1996) Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol 157: 2728-2735. (Pubitemid 126450492)
44. Fruhwirth M, Ruedl C, Ellemunter H, Bock G, Wolf H (1998) Flow-cytometric evaluation of oxidative burst in phagocytic cells of children with cystic fibrosis. Int Arch Allergy Immunol 117: 270-275. (Pubitemid 29026909)
45. McLaughlin NJ, Banerjee A, Kelher MR, Gamboni-Robertson F, Hamiel C, et al. (2006) Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. J Immunol 176: 7039-7050. (Pubitemid 43787885)
46. Lacy P (2006) Mechanisms of degranulation in neutrophils. Allergy Asthma Clin Immunol 2: 98-108.